- Moss Genomics (MSSGF, Financial) commits 1,000 ETH to STRAT presale as part of its Ethereum Treasury Strategy.
- The STRAT presale aims to raise 6,900 ETH from strategic investors.
- Moss progresses in blockchain integration with a non-binding term sheet for investment in Genomes.io.
Moss Genomics (OTCQB: MSSGF) has announced notable progress in its Ethereum Treasury Strategy by contributing an initial 200 ETH with a pledge to add 800 ETH more to the STRAT presale. This strategic move aligns with Moss's ambition to integrate blockchain technology into genomic data management.
STRAT is an innovative on-chain smart contract platform designed to manage ETH-based capital flows through algorithmic mechanisms. The presale targets a significant raise of 6,900 ETH from a select group of strategic investors, leveraging Ethereum’s transparency by operating without intermediaries or custodians.
Continuing its blockchain expansion, Moss Genomics has previously laid out a non-binding term sheet for a strategic investment in Genomes.io, a genomics platform concentrating on decentralized data storage and patient privacy. This venture is part of Moss's broader vision to harness blockchain infrastructure to revolutionize secure genomic data management.
Furthermore, Moss Genomics is still moving towards fulfilling its private placement financing announced in February 2025, with ongoing updates anticipated as developments unfold. This financing is part of the company's broader efforts to support its pioneering initiatives in privacy-preserving genomic applications.
